Kumar Ajay Mv, Gupta Devesh, Kumar Ashok, Gupta R S, Kanchar Avinash, Rao Raghuram, Shastri Suresh, Suryakanth M D, Rangaraju Chethana, Naik Balaji, Guddemane Deepak K, Bhat Prashant, Nair Achuthan Sreenivas, Harries Anthony David, Dewan Puneet
International Union Against Tuberculosis and Lung Disease (The Union), South-East Asia Regional Office, New Delhi, India.
Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, New Delhi, India.
PLoS One. 2016 May 31;11(5):e0156487. doi: 10.1371/journal.pone.0156487. eCollection 2016.
In March 2012, World Health Organization recommended that HIV testing should be offered to all patients with presumptive TB (previously called TB suspects). How this is best implemented and monitored in routine health care settings in India was not known. An operational research was conducted in Karnataka State (South India, population 64 million, accounts for 10% of India's HIV burden), to test processes and learn results and challenges of screening presumptive TB patients for HIV within routine health care settings.
In this cross-sectional study conducted between January-March 2012, all presumptive TB patients attending public sector sputum microscopy centres state-wide were offered HIV testing by the laboratory technician, and referred to the nearest public sector HIV counselling and testing services, usually within the same facility. The HIV status of the patients was recorded in the routine TB laboratory form and TB laboratory register. The laboratory register was compiled to obtain the number of presumptive TB patients whose HIV status was ascertained, and the number found HIV positive. Aggregate data on reasons for non-testing were compiled at district level.
Overall, 115,308 patients with presumptive TB were examined for sputum smear microscopy at 645 microscopy centres state-wide. Of these, HIV status was ascertained for 62,847(55%) among whom 7,559(12%) were HIV-positive, and of these, 3,034(40%) were newly diagnosed. Reasons for non-testing were reported for 37,700(72%) of the 52,461 patients without HIV testing; non-availability of testing services at site of sputum collection was cited by health staff in 54% of respondents. Only 4% of patients opted out of HIV testing.
Offering HIV testing routinely to presumptive TB patients detected large numbers of previously-undetected instances of HIV infection. Several operational challenges were noted which provide useful lessons for improving uptake of HIV testing in this important group.
2012年3月,世界卫生组织建议应对所有疑似结核病患者(以前称为结核病疑似者)进行艾滋病毒检测。在印度的常规卫生保健机构中如何最好地实施和监测这一建议尚不清楚。在卡纳塔克邦(印度南部,人口6400万,占印度艾滋病毒负担的10%)开展了一项运筹学研究,以测试在常规卫生保健机构中对疑似结核病患者进行艾滋病毒筛查的流程,并了解结果和挑战。
在2012年1月至3月进行的这项横断面研究中,全州公共部门痰涂片镜检中心的所有疑似结核病患者均由实验室技术人员提供艾滋病毒检测,并转介至最近的公共部门艾滋病毒咨询和检测服务机构,通常就在同一机构内。患者的艾滋病毒状况记录在常规结核病实验室表格和结核病实验室登记册中。编制实验室登记册以获取已确定艾滋病毒状况的疑似结核病患者数量以及艾滋病毒检测呈阳性的患者数量。在地区层面汇总未检测原因的总体数据。
总体而言,全州645个镜检中心对115308例疑似结核病患者进行了痰涂片镜检。其中,62847例(55%)的艾滋病毒状况得以确定,其中7559例(12%)艾滋病毒检测呈阳性,其中3034例(40%)为新诊断病例。在52461例未进行艾滋病毒检测的患者中,37700例(72%)报告了未检测的原因;54%的受访者称,卫生工作人员表示在痰液采集地点没有检测服务。只有4%的患者选择不进行艾滋病毒检测。
对疑似结核病患者常规进行艾滋病毒检测发现了大量以前未被发现的艾滋病毒感染病例。注意到了几个操作方面的挑战,这些挑战为改善这一重要群体中艾滋病毒检测的接受度提供了有益的经验教训。